Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Innovacell Biotechnologie AG
DescriptionAutologous myoblasts expanded ex vivo and delivered in combination with ultrasound-guided injection system
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat stress urinary incontinence (SUI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today